74 related articles for article (PubMed ID: 427787)
1. Inhibitory effect of prostaglandin F2 alpha on the growth of a hormone-dependent rat mammary tumor.
Jubiz W; Frailey J; Smith JB
Cancer Res; 1979 Mar; 39(3):998-1000. PubMed ID: 427787
[TBL] [Abstract][Full Text] [Related]
2. Effect of high-dose progesterone on growth of rat mammary carcinoma.
Diamond EJ; Koprak S; Hollander VP
Cancer Res; 1980 Apr; 40(4):1091-6. PubMed ID: 7357540
[No Abstract] [Full Text] [Related]
3. Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion.
Ip MM; Sylvester PW; Schenkel L
Cancer Res; 1986 Apr; 46(4 Pt 1):1735-40. PubMed ID: 3948162
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the actions of RU 38486 and megestrol acetate in the model of a transplantable adrenocorticotropin- and prolactin-secreting rat pituitary tumor.
Lamberts SW; Uitterlinden P; Bons EG; Verleun T
Cancer Res; 1985 Mar; 45(3):1015-9. PubMed ID: 2982481
[TBL] [Abstract][Full Text] [Related]
5. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
Ip MM; Milholland RJ; Rosen F; Kim U
Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
[TBL] [Abstract][Full Text] [Related]
6. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
7. Hormone, serum, and methylxanthine interactions in the regulation of DNA synthesis in organ-cultured rat mammary tumors.
Mayer RM; Diamond EJ; Hollander VP
J Natl Cancer Inst; 1980 Nov; 65(5):1033-8. PubMed ID: 6159497
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
9. Prolactin-dependent rat mammary cancer: a model for man?
Pearson OH; Llerena O; Llerena L; Molina A; Butler T
Trans Assoc Am Physicians; 1969; 82():225-38. PubMed ID: 5375151
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in the hormonal responsiveness of clones derived from the 13762NF rat mammary tumor.
Geradts J; Richards J; Edery M; Pang K; Larson L; Nandi S
Cancer Res; 1986 Apr; 46(4 Pt 2):1920-7. PubMed ID: 3004710
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of the antiestrogen, tamoxifen, ona pregnancy-dependent mouse mammary tumor (TPDMT-4).
Matsuzawa A; Mizuno Y; Yamamoto T
Cancer Res; 1981 Jan; 41(1):316-24. PubMed ID: 7448771
[TBL] [Abstract][Full Text] [Related]
12. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors.
Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL
Cancer Res; 1989 Jun; 49(11):2945-51. PubMed ID: 2720654
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ovariectomy-induced rat mammary tumor regression by a mammosomatotropic tumor.
Diamond EJ; Khan S; Koprak S; Hollander VP
Cancer Res; 1978 Aug; 38(8):2239-45. PubMed ID: 208762
[No Abstract] [Full Text] [Related]
14. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of deferoxamine mesylate and low iron diet on the 13762NF rat mammary adenocarcinoma.
Wang F; Elliott RL; Head JF
Anticancer Res; 1999; 19(1A):445-50. PubMed ID: 10226580
[TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibitors--IV. Regression of hormone-dependent, mammary tumors in the rat with 4-acetoxy-4-androstene-3,17-dione.
Brodie AM; Marsh D; Brodie HJ
J Steroid Biochem; 1979 Apr; 10(4):423-9. PubMed ID: 109701
[No Abstract] [Full Text] [Related]
17. Role of insulin-like growth factor-related peptides in the estradiol-, prolactin-, and progesterone-stimulated growth of N-nitrosomethylurea-induced rat mammary tumors in soft agar.
Manni A; Wright C; Badger B; Lynch J; Demers L
Cancer Res; 1990 Nov; 50(22):7179-83. PubMed ID: 2224853
[TBL] [Abstract][Full Text] [Related]
18. Regression of rat mammary tumors associated with suppressed growth hormone.
Phares CK
Anticancer Res; 1986; 6(4):845-8. PubMed ID: 3019224
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition and eicosanoid metabolism in the R3230AC mammary adenocarcinoma by interferon.
Karmali RA; Schellekens H; Lefevre F; Marsh J; Fuchs C; Krim M
Cancer Treat Rep; 1986 Mar; 70(3):397-400. PubMed ID: 2420445
[TBL] [Abstract][Full Text] [Related]
20. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
Tamarkin L; Cohen M; Roselle D; Reichert C; Lippman M; Chabner B
Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
